The Open Science Forum features monthly talks from scientists from NIH-funded Antiviral Drug Discovery (AViDD) Centers who elect to provide updates on target priorities, advertise available resources and reagents, disclose chemical matter and associated antiviral data, share findings regarding in vivo efficacy models, discuss downstream development and translation models, and share ideas.
Moderator: Peter Sjö, Head of Drug Discovery Programme, DNDi
|Epidemiological, clinical and immunological risk factors of severe dengue|
Neelika Malavige, Head of Dengue Global Programme and Scientific Affairs, DNDi
|Dengue Drug Discovery|
Pei-Yong Shi, Director, Institute for Drug Discovery (IDD), Associate Chief Research Officer, and Vice President for Research Innovation, UTMB